In a superoxide dismutase 2 (SOD2) transgenic mouse model, development of synucleinopathies was significantly earlier as compared to the control mouse model which proved that a compromise in the capacity to quench free radical led to enhanced fibrillation of α-synuclein (Scudamore and Ciossek, 2018). Here, SOD2 is linked to synucleinopathy.